Clinical advantages of new peritoneal dialysis solutions.

Raymond T Krediet, Roos van Westrhenen, Machteld M Zweers, Dirk G Struijk

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 3():16-8

PMID: 11912294

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

A review is given of the various mechanisms by which conventional glucose/lactate-based peritoneal dialysis solutions can induce damage to the peritoneal membrane. The potential advantages of newly developed dialysis solutions and the results of recent studies on their use in patients are discussed.

Address: Division of Nephrology, Department of Medicine, Academic Medical Centre University of Amsterdam, Amsterdam, The Netherlands.

DOI: 10.1093/ndt/17.suppl_3.16

Link outs

Subscription / membership required

Full Text Sources:

MeSH Terms: Amino Acids, Bicarbonates, Dialysis Solutions, Glucans, Glucose, Humans, Icodextrin, Lactic Acid, Peritoneal Dialysis